OppenheimerFunds’s Supernus Pharmaceuticals SUPN Stock Holding History

OppenheimerFunds’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$203K	Buy	+5,796	New	+$216K	﹤0.01%	1706
2018 Q4	–	Sell	-331,809	Closed	-$16.7M	–	1858
2018 Q3	$16.7M	Buy	331,809 +26,407	+9%	+$1.3M	0.02%	629
2018 Q2	$18.3M	Buy	305,402 +33,092	+12%	+$1.71M	0.02%	607
2018 Q1	$12.5M	Sell	272,310 -139,702	-34%	-$5.83M	0.02%	667
2017 Q4	$16.4M	Buy	412,012 +15,538	+4%	+$614K	0.02%	642
2017 Q3	$15.9M	Buy	396,474 +137,237	+53%	+$5.94M	0.02%	645
2017 Q2	$11.2M	Buy	259,237 +252,683	+3,855%	+$8.99M	0.01%	719
2017 Q1	$205K	Buy	+6,554	New	+$176K	﹤0.01%	1819

Other funds holding SUPN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

NPIC

Neumeier Poma Investment Counsel Carmel, California $1.21B AUM 70.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

OppenheimerFunds's SUPN Position: Q1 2019 in Review

OppenheimerFunds opened a new position in Supernus Pharmaceuticals (SUPN) in Q1 2019: 5,796 shares worth $203K. The stake represents ﹤0.01% of the portfolio and ranks #1706 among its holdings. This is a return to the name: OppenheimerFunds previously reported a position in SUPN as recently as Q3 2018.

OppenheimerFunds first reported a position in SUPN in Q1 2017 and has held it in 8 quarters since. The position peaked at $18.3M in Q2 2018. 289 funds tracked by Wall St. Rank hold SUPN as of Q1 2019.

OppenheimerFunds held 5,796 shares of Supernus Pharmaceuticals worth $203K as of Q1 2019.
Supernus Pharmaceuticals was a new OppenheimerFunds position in Q1 2019.
Supernus Pharmaceuticals made up ﹤0.01% of OppenheimerFunds's portfolio in Q1 2019, its #1706 holding.
OppenheimerFunds first reported a position in Supernus Pharmaceuticals in Q1 2017 and has held it in 8 quarters since.
OppenheimerFunds's Supernus Pharmaceuticals position peaked at $18.3M in Q2 2018.
289 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.